Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy's Lab suspends worldwide supply of Ranitidine

Date: 23-09-2019

Dr. Reddy's Laboratories has suspended supply of its drug Ranitidine worldwide as a precautionary measure, following the ongoing probe by the US Food and Drug Administration (USFDA) into the reported impurity N-nitrosodimethylamine in it at low levels. Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.